Scientific activity and scientific production
"Cima's scientific activity has generated publications in journals of high scientific impact, patented biomedical inventions and coordination in international projects."
GLORIA GONZÁLEZ ASEGUINOLAZA
DEPUTY DIRECTOR. CIMA UNIVERSIDAD DE NAVARRA
Scientific production in data
During 2021, Cima's scientific activity recorded a total of 261 publications in high impact journals.
261
scientific publications in total
211
scientific publications
in the first quartile
11,80
average impact factor
with authorship
Our research results in high impact journals
Scientific activity of the
Cima Universidad de Navarra
Latest scientific publications
- The oncolytic adenovirus Delta-24-RGD in combination with ONC201 induces a potent antitumor response in pediatric high-grade and diffuse midline glioma models Mar 31, 2024 | Magazine: Neuro-Oncology
- An international worldwide retrospective cohort observational study comparing primary cytoreductive surgery with neoadjuvant chemotherapy and interval cytoreductive surgery in patients with carcinoma of the ovary, fallopian tubes, and peritoneum (SUROVA trial) Mar 13, 2024 | Magazine: International Journal of Gynecological Cancer
- Clinical evaluation of a low-coverage whole-genome test for detecting homologous recombination deficiency in ovarian cancer Mar 2, 2024 | Magazine: European Journal of Cancer
- Advancing with cancer immunotherapeutics: CD29+ regulatory T cell antagonism Feb 23, 2024 | Magazine: Gut
Cancer gene therapy
Active
Colorectal cancer therapy based on optimized immune checkpoint inhibitors using self-replicating RNA
Cima Principal Investigator:
Cristian Smerdou Picazo
Funder:
Instituto de Salud Carlos III
Award year
2022
Therapeutic Genes for Neurodegenerative Diseases
Active
CRCNS: Deep Learning to Discover Neurovascular Disruptions in Alzheimer's Disease
Cima Principal Investigator:
Ana Mª García Osta
Funder:
Instituto de Salud Carlos III
Award year
2023
Aptamers
Active
Selective blockade of the IL6/STAT3/SMG1 pathway in multiresistant circulating tumor cells (CTCs) as a pathway of sensitization to oncoimmunotherapy
Cima Principal Investigator:
Fernando Pastor Rodríguez
Funder:
Instituto de Salud Carlos III
Award year
2023
Therapeutic long non-coding RNAs and integrated stress in Cancer
Active
Rational to modulate the Microbiome-induced Endoplasmic Reticulum stress as tool to avoid the immune evasion in Hepatocellular Carcinoma (RETO)
Cima Principal Investigator:
Josepmaría Argemí
Funder:
Instituto de Salud Carlos III